STAG2 and cancer: By performing non-negative matrix factorization (NNMF) of the sequences (as in Polak et al., 2017), we identified 5 signatures associated with SA2-proficient cancers and 5 signatures associated with SA2-deficient cancers (Figure 7A; Table S1).